We first measured the effects of trace levels of an endocrine disruptor, tributyltin (TBT), on the secretion response from nerve cells using a microfabricated biosensor designed for the continuous measurement of L-glutamate and hydrogen peroxide. We observed higher and long-lasting glutamate and hydrogen peroxide concentrations from the cells when cultured rat cortical neurons were exposed to TBT. Glutamate and hydrogen peroxide release was induced even when we reduced the TBT concentration to 10 nM. This concentration is about two orders of magnitude lower than the concentration that induced apoptosis-like cell death. We also report on the effects of NMDA and non-NMDA receptor antagonists, which can help us to understand the mechanism of TBT neurotoxicity.
Introduction
The use of organotin compounds as biocides in antifouling paints and food preservatives leads to the contamination of marine and freshwater environments. Tributyltin (TBT) in organotin compounds has been shown to be highly toxic to a wide variety of aquatic animals. For the past 20 years, because the use of organotin compounds has been regulated by law throughout the world, the pollution concentrations around coastlines have decreased. However, the concentration of TBT is not sufficiently low, because organotin compounds are well known as endocrine disruptors, which induce a number of harmful effects in animals, even at very low levels.
Blaber et al. first described 1 the pseudohermaphroditism caused by organotin compounds in 1970. They discovered the occurrence of a penis-like outgrowth in female Nucella lapillus. Subsequently, several studies have reported that the development of male sex organs on female snails is induced by organotin compounds. This phenomenon contrasts with the behavior of other endocrine disruptors, which act as estrogen. It is thought that mutation caused by organotin compounds is a consequence of the inhibition of aromatase cytochrome P450 or the secretion of androgen. 2, 3 In recent years, the toxicity of organotin compounds in mammals has also been reported. Regarding the acute toxicity of organotin, Attahiru et al. reported 4 that the lethal dose 50 for 24 h was 297.54 mg/kg.
In relation to reproductive abnormalities, there is a reduction in both the number and weight of surviving embryos, and cleft palates are frequently observed. [5] [6] [7] [8] [9] [10] Moreover, reports on the toxicity of organotin compounds with regard to mammalian brains have stated that TBT induces epilepsy and amnesia. [11] [12] [13] Thompson et al. suggested 14 that TBT induced apoptosis.
Although there have been several reports indicating the toxicity in humans or experimental animals, the toxicity mechanism in mammalian brains has not been completely elucidated or discussed. [11] [12] [13] [14] [15] Very recently, Mizuhashi et al. reported 15 that TBT induced a permanent increase in the calcium concentration in rat nerve cells, and caused apoptosis-like cell death. They suggested the possibility of apoptosis based on their viability study of cultured rat hippocampal cells in the presence of TBT (> 3 µM). They also reported that apoptosislike cell death is suppressed in the presence of catalase and CNQX. Since catalase decomposes hydrogen peroxide, and CNQX is a non-NMDA receptor antagonist, we assume that the continuous monitoring of hydrogen peroxide and glutamate might prove to be very important for studying the effects of TBT on nerve cell death. Various microfabricated biosensors have been reported concerning their application to the continuous measurements of in vivo and in vitro biomolecules. [16] [17] [18] [19] A faster response with a lower detection limit and offering multiple analyte detection has been achieved by miniaturization.
We have developed various types of on-line sensors for the continuous monitoring of neurotransmitters and metabolites, such as glutamate, histamine, acetylcholine, glucose and lactate. 20, 21 More recently, we reported on a microfabricated biosensor that integrates dual detection electrodes in two channels. 22 We used one electrode for measuring glutamate and the other for measuring the background and stimulation noise. By deducting the latter signals from the former, we improved both the selectivity and the detection limit.
In this paper, we report on our study of the effect of on endocrine disruptor, TBT, on cultured rat cortical neurons by employing our integrated biosensor for the continuous monitoring of glutamate and hydrogen peroxide. We also report on the lower limit of the TBT concentration that causes neurotransmitter secretion from nerve cells and the roles of catalase and CNQX, which we determined by using this procedure.
Experimental

Chemicals
TBT and dimethyl sulfoxide were purchased from KantoKagaku (Tokyo, Japan). Glutamate oxidase (GluOx) from streptomyces sp. X-119-6 was purchased from Yamasa Shoyu (Choshi, Japan). L-Glutamate was purchased from Funakoshi Chemicals (Tokyo, Japan). Osmium-poly (vinylpyridine) wired horseradish peroxidase (Os-gel-HRP) was purchased from Bioanalytical Systems (West Lafayette, IN). Bovine serum albumin (BSA) was purchased from Sigma (St. Louis, MO). The external medium used for the measurement from nerve cells contained 148 mM NaCl, 2.8 mM KCl, 2 mM CaCl2, 2mM MgCl2, 10 mM glucose, 10 mM HEPES and was adjusted to pH 7.4.
Microfluidic device and measurement
We described the procedure that we used for fabricating the microfluidic device in detail in a previous report. 22 The microfabricated device consists of two glass plates and two glass capillaries. One glass plate has four carbon electrodes and the other glass plate has two channels to enable the glass capillaries to be fitted. The two glass capillaries are used as a sampling capillary, and an outlet capillary to which we connect a syringe pump. The two working electrodes are arranged in parallel in a thin-layer flow channel. We modified one working electrode with a bilayer of Os-gel-HRP/BSA containing GluOx, and the other with a bilayer of Os-gel-HRP/BSA without GluOx.
When we measured the glutamate and hydrogen peroxide release from nerve cells, we fixed the microfabricated device to a manipulator so as to control the distance between the cells and the end of the sampling capillary under microscope observation. We connected the other capillary to a syringe, and installed it in a CMA 102 dual syringe pump (Stockholm, Sweden) to introduce an extracellular solution into the microfabricated device in a suction mode. We connected the four pads of the microfabricated device to two LC-4C potentiostats (BAS) and stored the data in a computer using an analog/digital converter DA-5 (BAS). The flow rate was 1 µl/min, and the two working electrodes were held at -50 mV versus a reference electrode (carbon film electrode coated with Ag paste) in the microfabricated device. We used rat cortical neurons cultured for about 1 -2 weeks. We detailed the cell culture procedure in a previous report. 22 TBT dissolved in dimethyl sulfoxide was diluted with more than 1000-times its volume of external medium and injected into a culture dish. We stimulated the cells by injecting a TBT solution to adjust the TBT concentrations to between 10 nM and 1 mM under continuous measurement. We also studied the variation in the glutamate and hydrogen peroxide concentrations in the presence of catalase and CNQX.
Results and Discussion
Microfabricated device for measuring glutamate and hydrogen peroxide
We used the microfabricated device integrated with two working electrodes, a reference electrode and a counter electrode. One of the working electrodes was modified with a bilayer of Os-gel-HRP/BSA film containing GluOx, and the other was modified with the same film without GluOx. We have already reported that this microfabricated device is useful for the highly selective measurement of glutamate in a differential measurement. 22 In the present work, we used this device to monitor both glutamate and hydrogen peroxide. The working electrode modified with Os-gel-HRP/BSA film containing GluOx could detect currents from both glutamate and hydrogen peroxide, because the hydrogen peroxide generated by glutamate oxidation with GluOx was detected electrochemically through Os-gel-HRP.
In contrast, the working electrode modified with Os-gel-HRP without GluOx could detect only hydrogen peroxide. Therefore, we could continuously monitor the concentration of hydrogen peroxide at the GluOx unmodified electrode and glutamate at the GluOx modified electrode by deducting the current from the hydrogen peroxide that was not produced by the enzymatic oxidation of GluOx. Figure 1 shows calibration curves of glutamate and hydrogen peroxide at both working electrodes at a flow rate of 1 µl/min. The cathodic current at one working electrode modified with GluOx was proportional to the glutamate concentration from 0.1 to 10 µM. In contrast, when we injected various concentrations of glutamate into the microfabricated device, we observed no current increase at the other working electrode without GluOx. This suggests that there was no hydrogen peroxide crosstalk from the GluOx-modified electrode to the unmodified electrode, even at a low flow rate of 1 µl/min. This was due to the separator formed between the two working electrodes, which prevented the hydrogen peroxide from diffusing to the neighboring electrode. In contrast, the cathodic currents at both working electrodes were proportional to the hydrogen peroxide concentration, since hydrogen peroxide was reduced at both working electrodes. The currents at the two working electrodes usually have different magnitudes. This is because the thickness of the modified layer containing GluOx was different from that without GluOx, since the difference between the currents at the two electrodes was only a few percent when we injected water-soluble ferrocene derivatives, which were directly oxidized at the electrode surface. However, we could estimate the glutamate concentration from Fig. 1 when we injected a solution consisting of a mixture of glutamate and hydrogen peroxide, since the ratio of hydrogen peroxide sensitivity at the two electrodes did not change over a wide concentration range. Therefore, we used our device for the continuous monitoring of glutamate and hydrogen peroxide when we injected TBT into the rat cortex culture.
Monitoring glutamate and hydrogen peroxide release from cultured nerve cells by TBT addition
In previous work, a rat hippocampal culture was mainly used for studying the effect of TBT on the viability of nerve cells. 15 The related report also stated that a similar effect could be observed when using rat cortical neurons. We used cortical neurons instead of hippocampal neurons since the preparation of cell cultures is easier. Figure 2 shows the variation in the glutamate (a) and hydrogen peroxide (b) concentrations near to the cultured rat cortical neurons exposed to 10 µM TBT. We calculated the glutamate response curve (trace a) by deducting 1/3 of the current at the electrode modified with a bilayer of Os-gel-HRP/BSA without GluOx from the current at the electrode modified with a bilayer of Os-gel-HRP/GluOx. This is because the hydrogen peroxide sensitivity of the GluOx modified electrode is 1/3 of that of the GluOx unmodified electrode, as shown in Fig. 1 . The glutamate concentration started to increase 2 min after TBT injection, and exhibited a peak. However, the concentration continued to gradually increase after the peak appeared. The hydrogen peroxide concentration also increased continuously. These response curves are clearly different from the glutamate release that occurred when the nerve cells were stimulated by KCl or electrically. [20] [21] [22] [23] [24] [25] [26] When we stimulated the cultured nerve cells with a high concentration of KCl, the glutamate release was a transient response, and there was no increase in the hydrogen peroxide concentration. 22 This is because the released glutamate molecules were usually taken up by neighboring glia cells or post synapses through glutamate transporters and receptors. Mizuhashi et al. reported that TBT induced a long-lasting elevation of the intracellular calcium concentration for over 1 h. 15 This suggests that the long-lasting glutamate release induced by TBT was due to this calcium concentration increase. Figure 3 shows the glutamate or hydrogen peroxide concentration changes near to nerve cells exposed to 10 µM TBT in a calcium free medium. The TBT-induced glutamate release from nerve cells was greatly suppressed in a calciumfree medium. This shows that TBT does not directly induce glutamate and hydrogen peroxide release. These results indicate that the glutamate release by TBT was induced by the increasing calcium concentration in the nerve cells, and was caused by a synaptic release. This also shows that our results are consistent with those of Mizuhashi et al.
We added a glutamate standard solution to an extracellular medium to confirm whether the hydrogen peroxide release was induced by TBT or by increasing the glutamate concentration near to the nerve cells. Figure 4 shows the glutamate and hydrogen peroxide concentrations near to the nerve cells when we added a 1 µM glutamate solution to the extracellular medium.
The cathodic currents at the GluOx-modified electrode increased rapidly when we injected a glutamate solution. The current exceeded the maximum current range for 2 min, since the sensor showed more than 10 nA for a 1 µM glutamate solution, as shown in Fig. 1 . In contrast, we observed no current changes at the GluOx unmodified electrode, which detected changes in the hydrogen peroxide concentration. These results suggest that the hydrogen peroxide release is induced by TBT, not by increasing the glutamate concentration.
After the glutamate solution had been added, the glutamate concentration decreased and in 10 min reached almost the same concentration as that before glutamate addition, suggesting that the glutamate uptake was relatively fast in our cortex culture. However, we observed a long-lasting high glutamate concentration increase near to the nerve cells when we added TBT, as shown in Fig. 2 . These results indicate that the longlasting glutamate release induced by TBT could be faster than the glutamate uptake into the cells, or that TBT prevents the uptake of glutamate into the cells. Figure 5 shows the changes in the glutamate and hydrogen peroxide concentration in the presence of 10 µM TBT with or without 100 µM glutamate antagonists, such as CNQX and MK801. Mizuhashi et al. reported that the viability of the nerve cells is greatly improved in the presence of catalase or CNQX. 15 With catalase, this is consistent with the idea that the nerve cells were protected from toxic hydrogen peroxide, which is immediately decomposed by the enzymatic reaction. As can be seen for the response curve without an antagonist (a1 and a2), both glutamate and hydrogen peroxide were released from nerve cells in the presence of CNQX or MK801. The concentrations of glutamate and hydrogen peroxide with CNQX or MK801 were even higher than those without them. This suggests that the higher concentration of glutamate with NMDA and non-NMDA receptor antagonists could have been due to the inhibition of glutamate uptake that resulted from the receptors being blocked by the antagonist. However, the apoptosis-like cell death was only suppressed when the culture medium contained CNQX. This clearly suggests that apoptosis-like cell death could be induced by stimulating non-NMDA receptors with a high concentration of released glutamate. In contrast, the apoptosis-like cell death might not be induced by glutamate, since the non-NMDA receptor was already blocked by CNQX. Figure 6 shows the variation in the glutamate concentration near to nerve cells 10 min after TBT addition as a function of the final concentration of TBT in the cultured medium. In the previous report, apoptosis-like cell death was observed when the TBT concentration in the culture medium was kept above 3 µM for 10 to 15 h. However, we observed a long-lasting glutamate release even when the nerve cells were exposed to 10 nM TBT. The extracellular glutamate concentration reached almost the same concentration of 0.1 -0.2 µM when we changed the TBT concentration from 0.1 mM to 10 nM. This might have been because the glutamate in the synaptic terminals was almost completely released by the long-lasting intracellular calcium elevation induced by TBT. This also suggests that even a very low concentration of TBT may have some effect on mammalian systems. However, further studies including in vivo experiments will be required to understand the risk that TBT poses to the nervous system.
Our method is also useful for screening the effects of trace amounts of endocrine disruptors on nerve cells, since we can measure the response in 2 min with a relatively small quantity of cells. In contrast, a cell-viability study requires more than 10 h with a higher TBT concentration.
When the final TBT concentration was higher than 1 mM, the glutamate concentration near to the nerve cells greatly increased. This was due to immediate cell death, since it has already been reported that a high concentration of TBT shuts down the calcium and sodium-potassium pumps. 27 The high glutamate concentration is due not to synaptic release, but to glutamate diffusion from inside the cells because of cell membrane rupture.
Conclusion
This paper reported on the glutamate and hydrogen peroxide release that occurs with the addition of various concentrations of an endocrine disruptor, TBT. We found that glutamate and hydrogen peroxide release was induced even with 10 nM TBT. The effect of endocrine disruptors on nerve cells has already been studied, but this is the first time that the effect of nanomolar levels of TBT has been measured rather than TBT toxicity. 28 Our device and method could be used for basic physiological studies of nerve cells, and will also prove to be useful for the rapid screening of environmental pollutants and their effects on the nervous system. Both the device and method are inexpensive, and only a few minutes are needed for the measurement, which compares favorably with cell-viability studies reported elsewhere. However, further studies are required to determine whether our method can be applied to systems using other endocrine disruptors and cells.
